Filing Details
- Accession Number:
- 0001209191-11-058219
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-11-28 18:02:03
- Reporting Period:
- 2011-11-01
- Filing Date:
- 2011-11-28
- Accepted Time:
- 2011-11-28 18:02:03
- Original Submission Date:
- 2011-11-02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405288 | A Jacqualyn Fouse | 86 Morris Avenue C/O Celgene Corp. Summit NJ 07901 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-01 | 1,000 | $63.92 | 8,085 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This form is being filed to amend the Form 4 filed on 11/02/2011 to correct the transaction code.